Myeloid dendritic cells (mDCs) have long been thought to function as classical APCs for T cell responses. However, we demonstrate that influenza viruses induce rapid differentiation of human monocytes into mDCs. Unlike the classic mDCs, the virusinduced mDCs failed to upregulate DC maturation markers and were unable to induce allogeneic lymphoproliferation. Virusinduced mDCs secreted little, if any, proinflammatory cytokines; however, they secreted a substantial amount of chemoattractants for monocytes (MCP-1 and IP-10). Interestingly, the differentiated mDCs secreted type I IFN and upregulated the expression of IFN-stimulated genes (tetherin, IFITM3, and viperin), as well as cytosolic viral RNA sensors (RIG-I and MDA5). Additionally, culture supernatants from virus-induced mDCs suppressed the replication of virus in vitro. Furthermore, depletion of monocytes in a mouse model of influenza infection caused significant reduction of lung mDC numbers, as well as type I IFN production in the lung. Consequently, increased lung virus titer and higher mortality were observed. Taken together, our results demonstrate that the host responds to influenza virus infection by initiating rapid differentiation of circulating monocytes into IFN-producing mDCs, which contribute to innate antiviral immune responses.
I
nfluenza is a disease of global public health significance. Each year in the United States alone, influenza results in an average of 20,000-40,000 deaths (1) . Influenza viruses possess a negative-sense ssRNA genome and are classified into types A, B, and C (2), according to their serologically distinct major internal proteins: the nucleoprotein (NP) and matrix protein (3) . Annual seasonal influenza epidemics are mainly caused by influenza A virus (IAV) and influenza B virus, whereas influenza A also causes sporadic pandemics. Upon viral infection, the immune system uses a number of mechanisms that are aimed at eradicating the viral attack. Innate immune cells, including NK cells, alveolar macrophages (AMs), and dendritic cells (DCs), all contribute to the direct control of viral replication and the induction and regulation of virus-specific adaptive immune responses (4, 5) . DCs are the most potent professional APCs and play a central role in bridging innate and adaptive immune responses. Lung-resident DCs are distributed throughout the respiratory tract in an immature state. Upon the recognition of unique pathogen motifs, pattern recognition receptors of DCs initiate signaling cascades that activate and mature the DCs. Activated DCs express increased levels of costimulatory molecules, produce cytokines and chemokines (6, 7) , and migrate to the draining lymph nodes where they induce Ag-specific CD8 T cells, as well as CD4 T cells, which aid in cellular and humoral immunity (7) . Lung DCs are a heterogenous population and consist primarily of myeloid DCs (mDCs)/conventional DCs and plasmacytoid DCs (pDCs).
Histiocytic precursors and monocytes can differentiate into immature DCs in vitro upon stimulation with GM-CSF and IL-4 (8) . However, during infection or inflammation, DCs differentiate more readily from the circulating monocytes than from bone marrow precursor cells (9, 10) . Inflammatory stimuli, such as viral or bacterial products or environmental pollutants, trigger the production of chemokines that attract monocytes and other inflammatory cells to the lungs. These monocytes can be the immediate precursor to inflammatory DCs (11) (12) (13) (14) . Patients with influenza virus infection tend to have greater numbers of monocytes and DCs in their nasal wash samples (15) . However, the source of these DCs in the respiratory tract is not known.
In this study, we investigated whether monocytes are a possible source of DCs in the respiratory tract and characterized the function of these cells in influenza virus infection. Our results provide evidence that influenza virus infection, but not TLR ligand stimulation, induces rapid differentiation of human blood-derived monocytes into mDCs. These influenza virus-induced mDCs are not classical professional APCs because they failed to undergo maturation and present alloantigens to CD4 and CD8 T cells. However, they secrete type I IFN and upregulate IFN-stimulated genes (ISGs), thereby contributing to host antiviral defenses. We confirmed our findings in murine studies, demonstrating that the depletion of monocytes prior to influenza virus infection leads to a reduction in type I IFN-secreting mDCs and reduced survival of mice. Taken together, these findings implicate a novel role for mDCs in antiviral innate immune responses against influenza virus infection.
Materials and Methods

Cells and cell lines
NHBE cells and A549 cells were obtained from Lonza (Basel, Switzerland) and the American Type Culture Collection (Manassas, VA), respectively. MDCK cells were obtained from the Centers for Disease Control and Prevention (CDC)'s Division of Scientific Resources. Citrated whole blood was collected from healthy volunteers under a protocol approved by the CDC's institutional review board, and PBMCs were isolated by centrifugation through Ficoll-Hypaque solution (Lymphoprep; Axis Shield, Oslo, Norway). 
Influenza viruses
Mice
Female C57BL/6 mice, 6-8 wk old, were purchased from The Jackson Laboratory (Bar Harbor, ME).
TLR ligands and regents
Ultrapure Escherichia coli LPS (0111:B4), polyinosinic-polycytidylic acid [Poly(I:C)], and R848 and CpGA (ODN 2336) DNA (all from InvivoGen, San Diego, CA) were used. RIG-I inhibitor (epigallocatechin gallate) was from Sigma.
In vitro influenza virus infection
Human PBMCs were cultured in RPMI 1640 containing 10% FBS, 100 U/ ml penicillin, 100 mg/ml streptomycin solution, and 2 mM L-glutamine (RPMI complete medium). A549 cells, a human epithelial cell line derived from lung adenocarcinoma (American Type Culture Collection), were grown in complete DMEM. For in vitro infection, viruses were diluted in medium containing 0.3% BSA. Cells were washed twice with medium only, and virus was added, at a volume of 100 ml at a multiplicity of infection (MOI) of 1.0, to each well. After 1 h of incubation with the virus, cells were washed with PBS and cultured in complete medium for FACS staining or in medium with 0.3% BSA and 1 mg/ml N-p-tosyl-L-phenylalanine chloromethyl ketone-treated trypsin (Sigma-Aldrich) for the virustiter assay. For the virus-inhibition assay in A549 cells, they were preincubated with UV-inactivated supernatants from purified monocytes infected overnight with A/Bris/59/07 virus or treated with PBS (mock infection). In some experiments, A549 cells were pretreated with mock supernatant plus rIFN-a and IFN-b (PBL InterferonSource, Piscataway, NJ) or A/Bris/59/07 supernatant with anti-IFN-a (clone 2 and 13) and anti-IFN-b (clone 3 and 15)-neutralizing Abs (PBL InterferonSource). For virus inactivation by UV irradiation, viruses or supernatants from virusinfected cultures were placed on ice and irradiated using a 254-nm UV stratalinker (Stratagene, La Jolla, CA) for 30 min. For heat inactivation, virus was incubated in a 56˚C water bath for 40 min. To assess the impact of cytokines and chemokines on influenza-induced monocyte differentiation, NHBE cells or PBMCs were infected with A/Bris/59/07 overnight; supernatants were collected and UV inactivated. Fresh human PBMCs were then primed with the UV-inactivated culture supernatants for 4-6 h, followed by infection with A/Bris/59/07 (MOI = 1) overnight.
Activation of PBMCs with TLR ligands
Human PBMCs were cultured with Poly(I:C) (10 mg/ml), LPS (1 mg/ml), R848 (5 mg/ml), and CpGA (10 mg/ml) for 16 h. Cells were then analyzed by flow cytometry to assess the frequencies of various cell types.
PBMC staining
PBMCs were isolated from citrated blood samples. Cells were resuspended in PBS containing 10% FBS and stained for flow cytometry. The following Abs were used for analysis of DC subsets in PBMCs: CD3-PE-Cy7, CD14-Alexa Fluor 700, CD19-PE-Cy7, CD56-PE-Cy7, CD123-PerCP-Cy5.5, CD11c-allophycocyanin, and HLA-DR-allophycocyanin-Cy7 (BD Bioscience). For detection of the expression of a-2,6-linked sialic acids and a-2,3-linked sialic acids, lectin Sambucus nigra agglutinin (SNA) and Maackia amurensis agglutinin (MAA I) (both FITC conjugated) (EY Laboratories) were used. For analysis of monocyte, macrophage, and neutrophil infiltration in mouse lung tissue, CD11c-allophycocyanin, CD45-Alexa Fluor 700, CD11b-Pacific Blue, B220-PE-Cy7, F4/80-PE, Ly6C-allophycocyanin-Cy7, Gr-1-allophycocyanin, and Ly6G-FITC (BD Bioscience) were used. For analysis of DC infiltration in mouse lung tissue, CD11c-allophycocyanin, CD45-Alexa Fluor 700, CD11b-Pacific Blue, B220-PE-Cy7, I-A/E-PE, and CD103-PerCP-Cy5.5 (all from BD Bioscience) were used. The following Abs were used for analysis of cell activation: HLA-DR-allophycocyanin-Cy7, CD40-PE, and CD86-FITC (all from BD Bioscience). Samples were analyzed using an LSRII flow cytometer (BD Biosciences), and the cytometry data were analyzed using FlowJo software (Tree Star). 
Cytokine detection
Virus titration by MDCK cell-based plaque assay
Confluent monolayers of MDCK cells in six-well plates were washed with DMEM and infected with serial 10-fold dilutions of cell culture supernatant for 1 h at 37˚C in 5% CO 2 . Cells were washed with DMEM and overlaid with 1.6% SeaKem LE agarose (Lonza) mixed 1:1 with 23 L15 medium (Lonza) containing 4 mM HEPES, 2 mM L-glutamine, 5 mg/ml gentamicin, 1.5 mg/ml sodium bicarbonate, and 1 mg/ml N-p-tosyl-L-phenylalanine chloromethyl ketone-treated trypsin (Sigma-Aldrich). Virus plaques were stained with 0.3% crystal violet solution (BD, Sparks, MD) after 72 h of incubation at 37˚C in 5% CO 2 and counted. 
MLR assay
Real-time PCR
Total RNA was isolated from sorted mDCs using the RNeasy Mini Kit (QIAGEN, Carlsbad, CA), and cDNA was generated using the Superscript First-Strand Synthesis System for RT-PCR using random hexamer primers (Invitrogen, Carlsbad, CA), according to the manufacturer's protocol. Resulting cDNA was diluted 1:5, and 2 ml was used in a SYBR Green (SA Bioscience, Frederick, MD)-based real-time PCR reaction using a Mx3000 real-time PCR instrument (Stratagene, Cedar Creek, TX). GAPDH or b-actin was used to normalize the Ct values. Primer sets used for these studies are listed in Table I .
In vivo studies
Female C57BL/6 mice were anesthetized with 2,2,2-tribromoethanol in tert-amyl alcohol (Avertin; Sigma-Aldrich) before intranasal inoculation with 100 50% mouse infectious dose (MID 50 ) of PR8 virus or PBS as a control. Lung tissues were collected on days 1, 3, 5, 7, and 10 postinfection (p.i.) to characterize cellular infiltrates by flow cytometry. In some animals, monocytes were depleted by clodronate-containing liposomes (5 mg/ml, 50 ml/each mouse; Encapsula NanoSciences, Nashville, TN) administered i.v. daily for 6 consecutive days, starting 18 h before PR8 infection. Control mice received an equivalent volume of PBS liposome. Cellular infiltrates in the lung were characterized on day 5 p.i. by flow cytometry. The animals were monitored for 14 d p.i. to assess morbidity. To determine lung viral titers, lungs were collected on days 3 or 5 p.i., each lung was homogenized in 1 ml cold PBS, and clarified homogenates were titrated in eggs to determine virus infectivity, starting at 1:10 dilution (limit of detection, 10 1.5 50% egg infective dose/ml). To assess the infection of monocytes in vivo, lung tissue was collected on day 5 p.i.; a single-cell suspension was prepared and stained for mDC markers, together with anti-NS1 Ab, to assess the presence of intracellular NS1 (an indication of virus infection). Animal research was conducted under the guidance of the CDC's Institutional Animal Care and Use Committee in an animal facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International.
Statistical analysis
All data were analyzed using Prism software (GraphPad Software). Data are expressed as mean 6 SD, and the significances of differences were determined by the unpaired Student t test; p values , 0.05 were considered significant.
Results
Influenza virus induced rapid differentiation of monocytes into mDCs
To examine the effect of influenza virus infection and TLR ligation, human PBMCs were infected with IAV or stimulated with Poly(I: C) (TLR3 ligand), LPS (TLR4 ligand), R848 (TLR7/8 ligand), and CpGA (TLR9 ligand) and analyzed by flow cytometry. As shown in low/2 mDCs, it had no such impact on pDC precursors. Similar data were obtained using PBMCs from multiple donors (Supplemental Fig. 1 ). DCs can originate either from common progenitor cells in the bone marrow or blood monocytes in the periphery (16, 17) . Accumulating evidence suggests that during infection or inflammation, DCs differentiate more readily from monocytes (9, 10) . Therefore, we examined whether the expanded mDCs were derived from monocytes. Monocytes were defined as CD14 with IAV can occur through the binding of viral surface hemagglutinin to sialylated glycans on the appropriate host cell (18, 19) . We then assessed the expression of influenza virus receptor on the surface of monocytes. Monocytes strongly bound to lectin SNA, which primarily detects influenza receptor a-2,6-linked sialic acids, but not to MAA I, which primarily detects a-2,3-linked sialic acids (Fig. 1E ). These findings suggest that monocytes expressed receptors used by human influenza viruses for entry into cells, which is consistent with a previous publication (20) . Indeed, 16 h p.i., ∼20-30% of monocyte-derived mDCs expressed IAV protein NS1, as detected by flow cytometry (Fig. 1F) . Collectively, our results suggest that blood-circulating monocytes can be infected by influenza virus, because NS1 can only be found in infected cells and then differentiated into mDCs.
Live influenza virus infection is required for monocyte differentiation
To determine whether rapid monocyte differentiation could also be induced by other strains of influenza viruses, we infected PBMCs with A/X-31 ( Fig. 2A) . This ability to induce mDCs is not restricted to A viruses; type B influenza virus (B/Brisbane/60/2008) has the same effect on monocyte differentiation (Fig. 2B) . These results suggest that monocyte differentiation into mDCs is a common mechanism in response to influenza virus infection. To examine whether viral replication is needed for the induction of mDCs, we infected PBMCs with live virus or heat-or UV-inactivated viruses. As shown in Fig. 2C , live virus infection was required for monocyte differentiation. Both UV-and heat-inactivated virus failed to induce monocyte differentiation. In vitro differentiation of DCs from monocytes using GM-CSF and IL-4 requires 5-7 d (8). In contrast, almost 100% of influenza virus-induced monocytes in PBMCs differentiated into mDCs by 16 h p.i. (Fig. 2D) . Supernatants from A/Bris/59/07-activated PBMCs or primary NHBE cells failed to induce differentiation of fresh monocytes (Supplemental Fig. 2 ). These data suggest that influenza virus-induced monocyte differentiation is live virus dependent and is not triggered by soluble mediators secreted by activated cells.
Influenza virus-induced mDCs exhibit impaired ability to mature and stimulate alloreactive T cells
As professional APCs, the typical DC function is to present Ags and trigger adaptive immunity. We next investigated whether influenza virus-induced mDC act as APCs. Activated DCs upregulate the expression of MHC class II and costimulatory molecules (CD86 and CD40). As shown in Fig. 3A , the expression of CD40, CD86, and MHC class II was substantially upregulated on mDCs activated by TLR ligands. However, there was little or no upregulation of these molecules on virus-induced mDCs (Fig. 3A) . Next, we purified the mDCs following A/Bris/59/07 infection or LPS stimulation and determined the expression of proinflammatory cytokines. Although LPS-stimulated mDCs had increased expression of proinflammatory cytokine genes, including IL-12p35, IL-12p40, TNF-a, and IL-6, A/Bris/59/07 infection failed to induce the expression of these genes assessed by real-time RT-PCR using primers listed in Table I (Fig. 3B) . Consistent with the gene-expression profile, Bio-Plex assay of cell culture supernatants of virus-induced mDCs demonstrated lower levels of proinflammatory mediators compared with LPS-activated mDCs (Fig. 3C) . Interestingly, mDCs differentiated from circulating blood monocytes upon influenza virus infection secreted large amounts of MCP-1 and IP-10, which are strong chemoattractants for monocytes (Fig. 3D) . Next, we evaluated whether the differentiated mDCs were able to stimulate T cells in an allogeneic T cell-proliferation assay. Naive CD45RA + CD45RO 2 CD4
T cells and CD45RA + CD27 + CD8 T cells from donors were sorted, labeled with CFSE, and cultured together with blood mDCs sorted from mock-or virus-stimulated PBMCs from a different donor. After 5 d of coculture, as demonstrated by CFSE dilution, the uninfected blood mDCs triggered substantial CD4 and CD8 T cell proliferation. However, virus-induced mDCs could not induce a proliferative T cell response (Fig. 3E) . Collectively, these results indicate that influenza virus-induced mDCs are poor in Ag presentation but could actively recruit more monocytes to the site of infection through production of MCP-1 and IP-10.
Influenza virus-induced mDCs exhibit antiviral activity
Because influenza virus-induced mDCs failed to function as conventional APCs as a result of their inability to upregulate costimulatory molecules and activate the allogeneic T cell prolifer- ative response, we examined their ability to contribute to the antiviral response through the secretion of type I IFN. PBMCs were stimulated with LPS or A/Bris/59/07 for 16 h. mDCs were isolated for RNA extraction, and IFN-a/b mRNA expression was detected by real-time PCR. A significant increase in IFN-a/b mRNA expression was detected in virus-activated mDCs compared with mock-infected or LPS-activated mDCs (Fig. 4A) . Furthermore, both IFN-a and IFN-b were detected in the culture supernatants of virus-activated mDCs, but neither was detected in the culture supernatant of mock-infected or LPS-activated mDCs (Fig. 4B) . Type I IFN exerts antiviral effects through the induction of antiviral proteins encoded by ISGs. A/Bris/59/07 infection, but not LPS, induced a potent induction of the IFN-stimulated antiviral genes tetherin, viperin, and IFITM3 in mDCs (Fig. 4C) . In addition, the cytosolic RNA sensors, RIG-I and MDA5, were upregulated in virus-differentiated mDCs (Fig. 4C) . Release of type I IFN and the expression of ISGs and RIG-I/MDA5 by virusdifferentiated mDCs suggest a possible role for mDCs in the antiviral response. Using an in vitro infection model, we tested whether the differentiated mDCs mediate a direct antiviral response. Purified monocytes were mock infected or infected with A/Bris/59/07 overnight. The culture supernatants were collected and inactivated with UV to prevent the replication of any virus present. A549 cells were preincubated with UV-inactivated culture supernatants for 30 min, followed by infection with A/Bris/59/07 virus. Viral replication was assessed by NP expression in the cell lysates, as well as the viral titer in the culture supernatant. Preincubation of A549 cells with supernatant from virus-induced mDCs resulted in a marked decrease in NP protein expression (Fig. 4D) , as well as a 60% reduction in virus titer in the culture supernatant (Fig. 4E) . Furthermore, the addition of 100 ng/ml of recombinant type I IFN decreased the virus titer in the culture supernatant. Similarly, the addition of anti-IFN-a and anti-IFN-b Abs significantly increased the virus titer (Fig. 4E) . In summary, influenza virus-induced mDCs exhibited a direct antiviral activity by producing type I IFN and upregulating the expression of ISGs/ RIG-I/MDA5. 
Influenza virus infection accumulates monocytes and mDCs in vivo in C57BL/6 mice
CD103
+ DCs preferentially localize to airway mucosa (22, 23) . As shown in Fig. 5A , the total number of monocytes in the lung increased significantly, peaking between 4 and 7 d p.i. As expected, influenza virus infection also promoted a significant increase in the number of DCs in the lung, with peak levels occurring on day 7 p.i., concomitant with the peak of monocytes (Fig. 5B) . Although mDCs, especially CD11b + mDCs, were the most numerous following influenza infection, pDCs and CD103 + mDCs were minor populations. As is the case with human monocytes, mDCs in mice were infected; 13-15% of mDCs expressed IAV protein NS1 (Fig. 5C) . Furthermore, on day 5 p.i., the CD11b + mDCs expressed type I IFN mRNA (Fig. 5D ) and secreted type I IFN in the culture supernatant (Fig. 5E ). Taken together, our results demonstrate that, in vivo, IAV infection indeed recruited a substantial number of monocytes to the lung, with a corresponding increase in the number of type I IFN-producing mDCs.
Monocyte depletion results in increased mortality and lung viral titer in influenza-infected mice
To determine the source and antiviral function of virus-induced mDCs in vivo, we selectively depleted monocytes by treating mice with clodronate liposomes. Intravenous injection of clodronate liposome was shown to substantially reduce Gr-1 high monocytes, but not neutrophils and AMs (24) , up to 24 h posttreatment. The depletion of monocytes was confirmed by the significant reduction in monocytes in lungs at 5 d p.i. by FACS staining (Fig.  6A) . Interestingly, at day 5 p.i., the number of mDCs in the lung tissue of clodronate liposome-treated mice was also substantially reduced (Fig. 6A) . Fifty percent of mice treated with clodronate liposome succumbed to infection (Fig. 6B) . Furthermore, there was a significant reduction in type I IFN in lungs of monocytedepleted mice (Fig. 6C) . The virus titer in lungs was increased by 12-fold in monocyte-depleted mice on day 5 p.i. (Fig. 6D) . These data indicate that monocyte depletion significantly reduced the number of virus-induced mDCs in lungs upon influenza virus infection. Furthermore, following influenza virus infection, monocyte depletion was associated with reduced type I IFN secretion and increased virus replication in the lungs and mortality.
Discussion
Early protection against viral infections relies on the rapid detection of viruses and optimal induction of the type I IFN response. DCs are pivotal in mounting an effective innate and adaptive re- sponse to influenza virus infection. Differentiation of monocytes into DCs with GM-CSF and IL-4 is the classical protocol for generating monocyte-derived DCs in vitro (8) . A range of different inflammatory stimuli that can induce monocyte-to-DC differentiation has been reported, including TLR ligand stimulation and viral or bacterial infections (25) . In our study, we demonstrated that monocytes differentiate into mDCs in response to influenza virus infection. More importantly, unlike the classical mDCs induced by TLR ligands and other pathogens, the influenza virusinduced mDCs acts like pDCs in that they produce type I IFN and subsequently upregulate ISGs as well as cytosolic virus sensors, RIG-1/MDA5, to facilitate antiviral responses.
Monocytes in the blood stream do not usually get infected by influenza virus, but they can be recruited into respiratory mucosa where they could come in contact with the progeny virus released from the infected airway epithelial cells. A recent study reported the inhibition of monocyte differentiation by IAV using in vitro GM-CSF-and IL-4-treated equine monocytes (26) . However, in our study, we demonstrated the differentiation of human blood circulating monocytes into DCs in response to IAV. Our results are consistent with the published clinical observations that patients with influenza virus infection had greater numbers of mDCs and monocytes, but not T cells, in nasal wash samples (15) .
TLR activation was reported to trigger the rapid differentiation of human monocytes into CD1b + DC-SIGN 2 DCs to promote T cell activation and secrete proinflammatory cytokines (27) . In our study, activation of TLR3, -4, -7/8, and -9 receptors using Poly (I:C), LPS, R848, and CpGA failed to generate Lin 2 HLA-DR + CD11c + CD123 low/2 mDCs from human blood circulating monocytes. However, influenza virus infection can effectively induce the monocytes' differentiation into mDCs. Furthermore, the monocyte differentiation induced by influenza virus is live virus dependent because only live virus, and not heat-or UV-inactivated virus, efficiently induced monocyte differentiation into mDCs. The cellular machinery responsible for the induction of mDC after virus infection remains unidentified. Cellular recognition of influenza virus is thought to be mediated by TLR3 and TLR7/8, which recognize dsRNA/ssRNA (28) . RIG-I and MDA5 recognize cytoplasmic uncapped 59triphosphate RNAs and cytoplasmic dsRNA, respectively (29) . More recently, NLRP3 was reported to mediate key innate and healing responses to IAV via the regulation of caspase-1 (30) . We demonstrated that TLR3 or TLR7/8 ligand stimulation is unable to differentiate mDCs from monocytes. In addition, influenza virus-induced monocyte differentiation does not rely on RIG-I recognition, because RIG-I inhibitor (epigallocatechin gallate) failed to block the differentiation of monocyte (Supplemental Fig. 3 ). Further studies are required to determine the role of other cellular proteins in the induction of mDC generation after virus infection. Furthermore, we did not observe any influenza virus strain and type dependency on monocyte differentiation, suggesting that this is a rather common innate immune mechanism in response to influenza virus infection.
Monocyte-derived mDCs generated by different inflammatory stimuli may differ in their functions. They can act as sentinels of the immune system, capturing Ags from infectious agents, and maturing to induce an optimal priming environment to generate adaptive immunity. It was also suggested that mDCs are pivotal players in the peripheral tolerance (31) . Although influenza virusinfected DCs in the PBMCs stimulate strong proliferative and cytolytic responses in human CD8 T cells after 5-6 d in culture (32) , this study showed that influenza virus-induced mDCs differentiated from monocytes failed to exhibit a functionally mature phenotype and did not produce proinflammatory cytokines. Furthermore, they failed to activate naive T cells in an allogeneic MLR. Therefore, the influenza virus-induced mDCs is not the primary DC subset that presents Ags to naive T lymphocytes. Our findings of the deficiency in the functional Ag-presenting capacity of influenza-induced DCs were similar to the findings of the effects that other viruses have on DCs (33) (34) (35) (36) (37) . Although influenza virus-induced mDCs failed to produce proinflammatory cytokines, they secreted substantial amounts of monocyte chemoattractant cytokines: IP-10 and MCP-1. The selective induction of monocytes, but not neutrophil-attracting chemokines, upon IAV infection of human monocytes was reported by another study (38) . MCP-1 concentrations in nasal wash samples were also shown to be significantly increased in patients with influenza virus infection (15) . Therefore, the differentiated mDCs actively provide a positive feedback to attract more monocytes to the site of infection as their precursors.
The rapid and massive induction of mDCs in the early stages of virus infection prompted us to investigate the role of this subset in antiviral immunity. The rapid production of type I IFN serves as primary host defense mechanisms against infection by many viruses (39) (40) (41) . As expected, influenza virus-induced mDCs produce type I IFN. The expression of tetherin, viperin, and IFITM3, antiviral genes induced by type 1 IFN, was significantly increased in virus-induced mDCs. Furthermore, the expression of RIG-I and MDA5, two intracellular detectors of viral pathogenassociated molecular patterns, was also increased. RIG-1 and MDA5 establish an antiviral state and mediate an IFN amplification loop that supports immune effector gene expression during virus infection (42) . Therefore, our study showed that mDCs differentiated from monocytes serve as an early host defense mechanism in response to influenza virus infection. Lung DCs are a heterogenous population of APCs, of which mDCs and pDCs are the main subsets. There is a highly specialized division of labor between different DC subsets in the lung. mDCs play a crucial role in Ag presentation but show rather limited capacities in type I IFN production; pDCs can produce large amounts of type I IFN and are thought to be the major source of the cytokines in vivo (43, 44) . The results presented in this article add to the current understanding about early antiviral activity in specialized immune cells and show that type I IFN production in response to virus replication is not solely a function of pDCs. A recent study showing that mDCs and AMs, but not pDCs, could be the primary producers of IFN-a in response to Newcastle disease virus infection (45) is consistent with our finding. It is possible that pDCs and mDCs complement each other in the early antiviral response by surveying different anatomical compartments or by responding to different pathogen components early in infection. Furthermore, the relative abundance of this novel subset of mDCs, compared with pDCs, at the infection site facilitates a more robust antiviral effect. Such type I IFN production may be critical for an early amplification of IRF-7, RIG-I, and other IFN-inducible proteins, allowing the host to mount a strong antiviral response before virally encoded antagonists are produced. In the in vitro A549 model of virus infection, we demonstrated that incubating A549 cells with UV-inactivated supernatants from A/Bris/59/07 virusstimulated monocytes rendered them resistant to subsequent viral infection. Therefore, our data demonstrated that influenza virusinduced mDCs secreted type I IFN and upregulated antiviral ISGs and RIG-I/MDA5 to exhibit direct antiviral immune function.
Consistent with in vitro findings with human PBMCs, the number of monocytes and mDCs in mouse lung tissue increased significantly upon influenza virus infection. Furthermore, the purified mDCs from lung tissue secreted substantial amounts of type I IFN. To further dissect out the critical role of influenza virus-induced mDCs and their source in vivo, we performed monocyte-depletion experiments using clodronate liposomes. The number of lung mDCs decreased as a result of the lack of precursors recruited to the lung; the mortality and virus titer in the lung increased in the monocyte-depleted animals. The increased susceptibility to influenza infection after depletion of monocytes was consistent with a significant reduction in type I IFN secretion in the lungs. Thus monocyte-depleted mice lacked the optimal innate immune response to combat the viral infection. These findings confirm the important role of monocytes in limiting influenza virus replication and further suggest that their antiviral effect is a result of serving as precursors to mDCs in response to influenza virus infection. McGill et al. (46) and Aldridge et al. (47) showed that protective influenza-specific CD8 T cell responses require interactions with DCs in the lung. Therefore, in our in vivo experimental setting, we cannot rule out the potential loss of DC:T cell interactions on increased mortality and lung viral titers, because we depleted monocytes that serve as precursors to DCs. Several recent studies emphasized the important role of lung macrophages in limiting virus replication and disease severity (48, 49) through intranasal, but not i.v., inoculation with clodronate liposome. Our data suggest that, in addition to lung macrophages, virus-induced mDCs could be a component of the early innate defense mechanism against influenza virus infection. Innate immunity is critical in the early containment of influenza virus infection. After primary exposure to a novel influenza virus, it takes 5-7 d for T cells to arrive in the lung to clear the virus. Hence, this defines an earlier time frame during which innate immunity is critical to detect virus and initiate an antiviral response prior to the synthesis of viral proteins that act as antagonists of antiviral-signaling pathways.
In summary, our findings indicate that the host responds to influenza virus infection by recruiting blood-circulating monocytes to the site of infection in the respiratory tract. The recruited monocytes then rapidly differentiate into mDCs as a result of virus infection/stimulation and secrete substantial amounts of monocyte chemoattractant (MCP-1 and IP-10) to actively recruit more monocytes as precursors to mDCs. More importantly, virusinduced mDCs secrete type I IFN and induce antiviral molecules, including tetherin, IFITM3, and viperin, as well as RIG-I/ MDA5, which are crucial players in the induction and activation of antiviral immunity.
